about
An overview of clinical and commercial impact of drug delivery systemsVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmThe Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood CellsTopical delivery of hyaluronic acid into skin using SPACE-peptide carriers.Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries.Topical delivery of siRNA into skin using SPACE-peptide carriers.Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid.A Review of Clinical Translation of Inorganic Nanoparticles.Non-affinity factors modulating vascular targeting of nano- and microcarriersUsing shape effects to target antibody-coated nanoparticles to lung and brain endothelium.Impact of particle elasticity on particle-based drug delivery systems.Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting.Site-specific structural analysis of a yeast prion strain with species-specific seeding activity.High Throughput Layer-by-Layer Films for Extracting Film Forming Parameters and Modulating Film Interactions with Cells.Layer-by-Layer Encapsulation of Probiotics for Delivery to the Microbiome.Synthesis of protein-based, rod-shaped particles from spherical templates using layer-by-layer assembly.Shape and size-dependent immune response to antigen-carrying nanoparticles.Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.MoS₂ field-effect transistor for next-generation label-free biosensors.Enhanced epidermal localization of topically applied steroids using SPACE™ peptide.Delivery of Exenatide and Insulin Using Mucoadhesive Intestinal Devices.Topical delivery of Cyclosporine A into the skin using SPACE-peptide.Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation.Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes.Fabrication of fillable microparticles and other complex 3D microstructures.Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells.Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches.Controlling the Growth of Staphylococcus epidermidis by Layer-by-Layer Encapsulation.BioTM buzz.Nanoparticles in the clinic.BioTM Buzz Volume 4, Issue 2.Polymeric Films for the Encapsulation, Storage, and Tunable Release of Therapeutic MicrobesNanoparticles in the clinic: An updateBioTM Buzz Volume 4, Issue 3Clinical translation of microbe-based therapies: Current clinical landscape and preclinical outlookA heat-stable microparticle platform for oral micronutrient deliveryNanotechnology intervention of the microbiome for cancer therapy
P50
Q27007143-0BA17B7E-89EC-4750-B969-85950EC7DD84Q27026630-6B779278-3E05-4750-BA49-6EDBE3D19DF0Q28550941-C4DC13EF-D936-4CB5-8794-F366BA42093DQ34028836-829F2DBE-94A4-487D-BB2E-BB34E81B37BEQ34028841-BAE2A462-F3A8-40DF-B1F3-BDACFF2C8BD6Q34079604-9C280455-ABCF-4AC1-9C01-5D265D200AC9Q34579964-C5D4A554-8596-4CA6-B565-EFBF44D07674Q35587915-9B7D3FD8-74B5-49CB-AE24-F52B2F46670FQ35751958-950CF663-A632-4A56-BE2B-EFD334A778D1Q35967907-FF99463B-75DA-498E-8C76-9983B83075ACQ36703526-2B7B7446-D928-4BB4-8B14-EC6B44133387Q36967705-607F3341-EBBC-423F-BCDA-8CCDD401F27AQ38710370-23382BEB-8C58-4D03-992B-B4BADF42F5B1Q38760096-223C0DB2-8F4B-4B5E-B047-8A18E9D5B468Q38906057-F2DDDC88-4D16-479C-AFB7-C5DEA011C891Q39440212-CAE29735-A246-40FF-B727-D0944C7B22F2Q42816108-D22DA262-461B-433E-90D2-CA92357A0DD4Q43097131-7C35A3BC-E359-4526-B2C5-1FDF2FF526ADQ44881845-FC9C1B65-818F-416C-A862-95D982E8E640Q46184185-19EA4863-C552-42ED-A499-A0710D64A7EBQ46297019-39A249F7-888F-4935-8DE0-51454FC9F07DQ46431442-72F8A3A5-91A5-4589-ADF7-C1C3EF7616CDQ46736498-6E3D36A2-30D2-4FD2-9A78-64113B65045EQ46929341-0B590418-B765-4B6A-AC5B-8AADCC4FC4B7Q46957205-4576EA05-CB73-42E0-9A94-2C2F244221FEQ46965315-1F460FB2-FC73-4D27-80F4-255B8EFCE2B7Q48294349-2F0F2AB5-119C-4C3E-9862-A63131A09EEEQ48344306-E6315E25-474E-4E6E-87E4-08078E9DEBF4Q49351130-75EDBD1B-8325-4B85-823D-3215295A2450Q50438830-C0F7934B-09FF-43F6-8D52-062E91D108C5Q52310185-0D302155-2B2C-480E-ACB7-BDE09A4F1869Q53678388-0E1EC0A5-D8B7-4102-9AF7-A93CF6BA5E93Q55003489-B22ED2D1-D872-4736-8A66-1A7966EA7905Q64913209-2A33E6E5-160E-45C4-A50E-ED589169A589Q89814350-D024ED9E-BA45-46DA-A156-F792BC80E4F8Q90404021-2CCDF507-5925-43F8-95E8-FF4DEC98A78CQ90404026-6938DBDE-5CF9-459C-8128-CE1A04F63263Q90677446-5A0E76CE-87BE-40C6-963B-27CBCB2814A4Q91271876-09DA2B05-DD00-43CB-AFCE-0E63B95B712BQ91698483-75C9B7F7-B7BE-4F6E-86E1-94D9C61D72A7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Aaron C Anselmo
@ast
Aaron C Anselmo
@en
Aaron C Anselmo
@es
Aaron C Anselmo
@nl
type
label
Aaron C Anselmo
@ast
Aaron C Anselmo
@en
Aaron C Anselmo
@es
Aaron C Anselmo
@nl
prefLabel
Aaron C Anselmo
@ast
Aaron C Anselmo
@en
Aaron C Anselmo
@es
Aaron C Anselmo
@nl
P106
P1960
LVpLmhEAAAAJ
P21
P31
P496
0000-0003-3290-7857